These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20337153)

  • 1. Changes of rhythm of vocal fundamental frequency in sensorineural hearing loss and in Parkinson's disease.
    Lee GS; Lin SH
    Chin J Physiol; 2009 Dec; 52(6):446-50. PubMed ID: 20337153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in voice fundamental frequency of sustained vowels in speakers with sensorineural hearing loss.
    Lee GS
    J Voice; 2012 Jan; 26(1):24-9. PubMed ID: 21227645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hearing aid amplification on voice F0 variability in speakers with prelingual hearing loss.
    Lee GS; Liu C; Lee SH
    Hear Res; 2013 Aug; 302():1-8. PubMed ID: 23648550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of speech noise on vocal fundamental frequency using power spectral analysis.
    Lee GS; Hsiao TY; Yang CC; Kuo TB
    Ear Hear; 2007 Jun; 28(3):343-50. PubMed ID: 17485983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective voice analysis of boys with profound hearing loss.
    Dehqan A; Scherer RC
    J Voice; 2011 Mar; 25(2):e61-5. PubMed ID: 21236637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audio-vocal responses of vocal fundamental frequency and formant during sustained vowel vocalizations in different noises.
    Lee SH; Hsiao TY; Lee GS
    Hear Res; 2015 Jun; 324():1-6. PubMed ID: 25749240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Frequency Following Response: Neural Representation of Envelope and Temporal Fine Structure in Listeners with Normal Hearing and Sensorineural Hearing Loss.
    Ananthakrishnan S; Krishnan A; Bartlett E
    Ear Hear; 2016; 37(2):e91-e103. PubMed ID: 26583482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orofacial Strength and Voice Quality as Outcome of Levodopa Challenge Test in Parkinson Disease.
    Lechien JR; Delsaut B; Abderrakib A; Huet K; Delvaux V; Piccaluga M; Khalife M; Harmegnies B; Saussez S; Blecic S
    Laryngoscope; 2020 Dec; 130(12):E896-E903. PubMed ID: 32239775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acoustic features of voice in patients with severe hearing loss.
    Mora R; Crippa B; Cervoni E; Santomauro V; Guastini L
    J Otolaryngol Head Neck Surg; 2012 Feb; 41(1):8-13. PubMed ID: 22498262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [F0 characteristics in Parkinsonian speech: Contrast between the effect of hypodopaminergy due to Parkinson's disease and that of the therapeutic delivery of L-Dopa].
    Ghio A; Robert D; Grigoli C; Mas M; Delooze C; Mercier C; Viallet F
    Rev Laryngol Otol Rhinol (Bord); 2014; 135(2):63-70. PubMed ID: 26521344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of Middle-Frequency Modulations in Vocal Fundamental Frequency to Different Vocal Intensities and Auditory Feedback.
    Lee SH; Fang TJ; Yu JF; Lee GS
    J Voice; 2017 Sep; 31(5):536-544. PubMed ID: 28268129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phonatory characteristics of parkinsonian speech before and after morning medication: the ON and OFF states.
    Goberman A; Coelho C; Robb M
    J Commun Disord; 2002; 35(3):217-39. PubMed ID: 12064785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Speech and voice disorders in Parkinson's disease].
    Martnez-Sánchez F
    Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Voice and Motor Disabilities of Parkinson's Disease.
    Majdinasab F; Karkheiran S; Soltani M; Moradi N; Shahidi G
    J Voice; 2016 Nov; 30(6):768.e17-768.e22. PubMed ID: 26725551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Aerodynamic Study of Phonations in Patients With Parkinson Disease (PD).
    Ikui Y; Nakamura H; Sano D; Hyakusoku H; Kishida H; Kudo Y; Joki H; Koyano S; Yamauchi A; Takano S; Tayama N; Hirose H; Oridate N; Tanaka F
    J Voice; 2015 May; 29(3):273-80. PubMed ID: 25795370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of levodopa on vocal function in Parkinson's disease.
    Sanabria J; Ruiz PG; Gutierrez R; Marquez F; Escobar P; Gentil M; Cenjor C
    Clin Neuropharmacol; 2001; 24(2):99-102. PubMed ID: 11307045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease.
    De Letter M; Santens P; De Bodt M; Van Maele G; Van Borsel J; Boon P
    Clin Neurol Neurosurg; 2007 Jul; 109(6):495-500. PubMed ID: 17509751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fundamental frequency change during offset and onset of voicing in individuals with Parkinson disease.
    Goberman AM; Blomgren M
    J Voice; 2008 Mar; 22(2):178-91. PubMed ID: 16950600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emotional speech in Parkinson's disease.
    Möbes J; Joppich G; Stiebritz F; Dengler R; Schröder C
    Mov Disord; 2008 Apr; 23(6):824-9. PubMed ID: 18307245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective analysis of vocal warm-up with special reference to ergonomic factors.
    Vintturi J; Alku P; Lauri ER; Sala E; Sihvo M; Vilkman I
    J Voice; 2001 Mar; 15(1):36-53. PubMed ID: 12269633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.